| ADR Ontology |
| ADR Term |
Papillary thyroid cancer |
| ADR ID |
BADD_A03283 |
| ADR Hierarchy |
|
| Description |
An ADENOCARCINOMA that originates from follicular cells of the THYROID GLAND and accounts for the majority of THYROID CANCER cases. Cells exhibit enlarged, oval, or elongated morphologies with clear, round, nuclei. Fusions of RET, NTRK1, TPM3, and PCM1 genes are associated with this cancer. [MeSH] |
| MedDRA Code |
10033701 |
| MeSH ID |
D000077273
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Carcinoma papillary thyroid | Papillary thyroid cancer | Thyroid papillary carcinoma | Thyroid Cancer, Papillary | Cancer, Papillary Thyroid | Cancers, Papillary Thyroid | Papillary Thyroid Cancer | Papillary Thyroid Cancers | Thyroid Cancers, Papillary | Thyroid Carcinoma, Papillary | Carcinoma, Papillary Thyroid | Carcinomas, Papillary Thyroid | Papillary Thyroid Carcinomas | Thyroid Carcinomas, Papillary | Papillary Carcinoma Of Thyroid | Papillary Thyroid Carcinoma | Familial Nonmedullary Thyroid Cancer | Nonmedullary Thyroid Carcinoma | Carcinoma, Nonmedullary Thyroid | Carcinomas, Nonmedullary Thyroid | Nonmedullary Thyroid Carcinomas | Thyroid Carcinoma, Nonmedullary | Thyroid Carcinomas, Nonmedullary |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
|
|
